ArticleJournal of clinical medicine2020

A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC.

Jaejun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.